This compound can provide necessary muscle energy, and support myocardial contraction, and is therefore widely used in clinical practice to improve heart function and treat heart-related diseases.
When using chemical factories sodium phosphocreatine, the skills mainly lie in dosage control, administration route, and drug treatment monitoring.
According to clinical needs, sodium creatine phosphate can be administered via intravenous infusion, typically at a dose of 1g each time, 1-2 times a day, and completed within 30 to 45 minutes.
In cardiac surgery, sodium creatine phosphate can also be added to cardiac arrest fluid to protect the myocardium, generally at a concentration of 10mmol/L.
In terms of effectiveness evaluation, the main functions of sodium creatine phosphate include protecting the structure and function of myocardial cells, improving cardiac pumping function, and promoting recovery after cardiac surgery.
Research has shown that chemical factories sodium phosphocreatine can significantly enhance the activation of Nrf2 and PGC-1 α pathways, reduce cell apoptosis, and maintain mitochondrial structure.
In addition, sodium creatine phosphate has shown good clinical effects in the treatment of pediatric viral myocarditis, including improving treatment efficacy, shortening symptom improvement time, and reducing the incidence of adverse reactions.
In terms of safety, adverse reactions of chemical factories sodium phosphocreatine are usually rare, but rapid intravenous injection of more than 1g of sodium phosphocreatine may cause a decrease in blood pressure, and high-dose administration may affect calcium metabolism and renal function.
Therefore, close monitoring of a patient's blood pressure and renal function is necessary for clinical use.
Overall, the clinical application value of sodium phosphocreatine has been widely recognized.
Through reasonable dosage control and strict treatment monitoring, sodium creatine phosphate can effectively improve cardiac function and provide important treatment support for heart disease patients.
With the continuous deepening of research on chemical factories sodium phosphocreatine, its potential in drug development and clinical applications will be further explored.